MERRIMACK PHARMACEUTICALS IN's ticker is MACKXXXX and the CUSIP is 590328100. A total of 137 filers reported holding MERRIMACK PHARMACEUTICALS IN in Q3 2015. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $99,000 | -83.2% | 79,825 | -27.0% | 0.00% | -75.0% |
| Q2 2016 | $589,000 | -85.6% | 109,300 | -77.7% | 0.00% | -87.5% |
| Q1 2016 | $4,103,000 | -40.7% | 490,200 | -44.0% | 0.03% | -44.8% |
| Q4 2015 | $6,920,000 | -19.9% | 875,900 | -13.7% | 0.06% | -17.1% |
| Q3 2015 | $8,636,000 | -31.9% | 1,014,850 | -1.0% | 0.07% | -39.1% |
| Q2 2015 | $12,676,000 | +1.4% | 1,025,600 | -2.6% | 0.12% | +9.5% |
| Q1 2015 | $12,506,000 | +49.6% | 1,052,700 | +42.3% | 0.10% | +54.4% |
| Q4 2014 | $8,357,000 | +504.3% | 739,600 | +369.6% | 0.07% | +518.2% |
| Q3 2014 | $1,383,000 | – | 157,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 5,000,000 | $20,400,000 | 4.19% |
| Consonance Capital Management LP | 9,067,998 | $36,997,000 | 4.06% |
| Lagoda Investment Management, L.P. | 1,522,529 | $6,212,000 | 2.13% |
| INDUS CAPITAL PARTNERS, LLC | 1,050,000 | $4,284,000 | 0.56% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 9,072,877 | $37,017,000 | 0.32% |
| GARRISON BRADFORD & ASSOCIATES INC | 77,700 | $317,000 | 0.29% |
| Cannell & Co. | 1,572,978 | $6,418,000 | 0.23% |
| Virtus ETF Advisers LLC | 179,625 | $733,000 | 0.22% |
| LeJeune Puetz Investment Counsel LLC | 3,976 | $161,000 | 0.12% |
| STONERIDGE INVESTMENT PARTNERS LLC | 221,838 | $905,000 | 0.12% |